Meropenem pharmacokinetics and pharmacodynamics in patients with ventilator-associated pneumonia

被引：15

作者：

de Stoppelaar, F

Stolk, L

van Tiel, F

Beysens, A

van der Geest, S

de Leeuw, P

机构：

[1] Univ Hosp Maastricht, Dept Clin Pharm, NL-6202 AZ Maastricht, Netherlands

[2] Univ Hosp Maastricht, Dept Med Microbiol, NL-6202 AZ Maastricht, Netherlands

[3] Univ Hosp Maastricht, Dept Internal Med, NL-6202 AZ Maastricht, Netherlands

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2000年 / 46卷 / 01期

关键词：

D O I：

10.1093/jac/46.1.150

中图分类号：

R51 [传染病];

学科分类号：

100401 [流行病与卫生统计学];

摘要：

引用

页码：150 / 151

页数：2

共 5 条

[1]

Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men [J].

Craig, WA .

CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :1-10

[2]

Mouton JW, 1996, J ANTIMICROB CHEMOTH, V38, P5

[3]

MATHEMATICAL EXAMINATION OF DUAL INDIVIDUALIZATION PRINCIPLES (I) - RELATIONSHIPS BETWEEN AUC ABOVE MIC AND AREA UNDER THE INHIBITORY CURVE FOR CEFMENOXIME, CIPROFLOXACIN, AND TOBRAMYCIN [J].

SCHENTAG, JJ ;

NIX, DE ;

ADELMAN, MH .

DICP-THE ANNALS OF PHARMACOTHERAPY, 1991, 25 (10) :1050-1057

[4]

Continuous infusion versus intermittent administration of meropenem in critically ill patients [J].

Thalhammer, F ;

Traunmüller, F ;

El Menyawi, I ;

Frass, M ;

Hollenstein, UM ;

Locker, GJ ;

Stoiser, B ;

Staudinger, T ;

Thalhammer-Scherrer, R ;

Burgmann, H .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (04) :523-527

[5]

Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy [J].

Thomas, JK ;

Forrest, A ;

Bhavnani, SM ;

Hyatt, JM ;

Cheng, A ;

Ballow, CH ;

Schentag, JJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (03) :521-527

← 1 →